AR075188A1 - Composicion que comprende acido chicorico y/o sus derivados, uso, kit - Google Patents
Composicion que comprende acido chicorico y/o sus derivados, uso, kitInfo
- Publication number
- AR075188A1 AR075188A1 ARP100100204A ARP100100204A AR075188A1 AR 075188 A1 AR075188 A1 AR 075188A1 AR P100100204 A ARP100100204 A AR P100100204A AR P100100204 A ARP100100204 A AR P100100204A AR 075188 A1 AR075188 A1 AR 075188A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- treat
- composition according
- derivatives
- acid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 10
- YDDGKXBLOXEEMN-IABMMNSOSA-L Chicoric acid Natural products C1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C([O-])=O)[C@H](C([O-])=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-L 0.000 title abstract 4
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 title abstract 4
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 title abstract 4
- 229930016920 cichoric acid Natural products 0.000 title abstract 4
- YDDGKXBLOXEEMN-PMACEKPBSA-N dicaffeoyl-D-tartaric acid Natural products O([C@H](C(=O)O)[C@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-PMACEKPBSA-N 0.000 title abstract 4
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 title abstract 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 abstract 4
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 2
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 abstract 2
- 241001468157 Lactobacillus johnsonii Species 0.000 abstract 2
- 235000009754 Vitis X bourquina Nutrition 0.000 abstract 2
- 235000012333 Vitis X labruscana Nutrition 0.000 abstract 2
- 240000006365 Vitis vinifera Species 0.000 abstract 2
- 235000014787 Vitis vinifera Nutrition 0.000 abstract 2
- 229940074360 caffeic acid Drugs 0.000 abstract 2
- 235000004883 caffeic acid Nutrition 0.000 abstract 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 2
- 239000004310 lactic acid Substances 0.000 abstract 2
- 235000014655 lactic acid Nutrition 0.000 abstract 2
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 2
- 235000002906 tartaric acid Nutrition 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241001608472 Bifidobacterium longum Species 0.000 abstract 1
- 244000298479 Cichorium intybus Species 0.000 abstract 1
- 235000007542 Cichorium intybus Nutrition 0.000 abstract 1
- 240000008415 Lactuca sativa Species 0.000 abstract 1
- 235000003228 Lactuca sativa Nutrition 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
- C12P7/46—Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/0102—Tannase (3.1.1.20)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Botany (AREA)
Abstract
Una composicion que permite suministrarle a un sujeto ácido tartárico y/o cafeico. Una composicion que comprende un ingrediente que contiene ácido chicorico y/o sus derivados, y una bacteria de ácido láctico capaz de hidrolizar ácido chicorico y/o sus derivados para generar ácido tartárico y/o cafeico. Reivindicacion 4: La composicion de acuerdo con cualquiera de las reivindicaciones 1 - 3, caracterizada porque la composicion es un producto alimenticio, un suplemento alimenticio o una bebida, o una composicion para la aplicacion parenteral. Reivindicacion 7: La composicion de acuerdo con cualquiera de las reivindicaciones 1 - 6, caracterizada porque la bacteria de ácido láctico se selecciona del grupo que consiste en L. johnsonii, B. Iongum y B. lactis, en particular Lactobacillus johnsonii (CNCM I-1225), B. longum BB 536, B. Iactis (CNCM I-3446) y B. lactis BB12. Reivindicacion 8: La composicion de acuerdo con cualquiera de las reivindicaciones 1 - 7, caracterizada porque el ingrediente que contiene ácido chicorico es un producto alimenticio natural, tal como lechuga, achicoria, diente de leon, uva, pulpa de uva; o combinaciones o extractos de éstos. Reivindicacion 10: uso de una composicion de acuerdo con una de las reivindicaciones 1 - 9, caracterizada porque es para la preparacion de una composicion para tratar o prevenir trastornos inflamatorios, en particular ligados a infecciones bacterianas y/o virales; para mejorar la capacidad antioxidante en un humano o animal; para tratar o prevenir los trastornos relacionados con el estrés oxidativo; para tratar o prevenir trastornos metabolicos, tales corno diabetes; para tratar o prevenir trastornos relacionados con la densidad mineral osea; y/o para tratar o prevenir el cáncer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09151390A EP2210504A1 (en) | 2009-01-27 | 2009-01-27 | Composition comprising chicoric acid and/or derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR075188A1 true AR075188A1 (es) | 2011-03-16 |
Family
ID=40635768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100100204A AR075188A1 (es) | 2009-01-27 | 2010-01-27 | Composicion que comprende acido chicorico y/o sus derivados, uso, kit |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110280848A1 (es) |
| EP (2) | EP2210504A1 (es) |
| JP (1) | JP2012515541A (es) |
| KR (1) | KR20110119723A (es) |
| CN (1) | CN102333455A (es) |
| AR (1) | AR075188A1 (es) |
| AU (1) | AU2010209797A1 (es) |
| BR (1) | BRPI1007194A2 (es) |
| CA (1) | CA2750685A1 (es) |
| CO (1) | CO6400174A2 (es) |
| MX (1) | MX2011007471A (es) |
| RU (1) | RU2011135819A (es) |
| WO (1) | WO2010086322A1 (es) |
| ZA (1) | ZA201106300B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1917960A1 (en) * | 2006-11-06 | 2008-05-07 | Nestec S.A. | Improved biological effects of rosmarinic acid |
| EP2588071B1 (en) * | 2010-06-30 | 2019-05-22 | Nestec S.A. | Use of chicoric acid and derivatives for lightening and/or whitening skin tone |
| ES2744576T3 (es) | 2010-06-30 | 2020-02-25 | Nestle Sa | Uso de ácido cicórico y bacteria láctica en suplemento alimenticio para aclarar y/o blanquear el tono de la piel |
| JP2013530996A (ja) * | 2010-06-30 | 2013-08-01 | ネステク ソシエテ アノニム | 皮膚の色素沈着を調節するための、栄養補助食品におけるカフタル酸及び誘導体の使用 |
| US20140242010A1 (en) * | 2011-10-11 | 2014-08-28 | Elc Management Llc | Method And Compositions For Treating Skin |
| WO2013190068A1 (en) | 2012-06-22 | 2013-12-27 | Nestec S.A. | Probiotic and polyphenol against neurodegeneration |
| CN105392491A (zh) * | 2013-03-12 | 2016-03-09 | Hmi医疗创新有限公司 | 具有抗糖尿病和其它有用活性的植物提取物 |
| CN103408423A (zh) * | 2013-07-17 | 2013-11-27 | 张家港威胜生物医药有限公司 | 一种天然活性产物l-菊苣酸的合成工艺 |
| KR20170032815A (ko) * | 2015-09-15 | 2017-03-23 | 경희대학교 산학협력단 | 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물 |
| WO2019181783A1 (ja) * | 2018-03-23 | 2019-09-26 | 森永乳業株式会社 | 臭い成分不活性化用組成物 |
| CN110786241B (zh) * | 2019-11-28 | 2022-03-22 | 大连市现代农业生产发展服务中心(大连市农业科学研究院) | 一种提高液体培养紫锥菊不定根中菊苣酸积累的培养方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU459273B2 (en) * | 1971-05-17 | 1975-03-20 | Sankyo Company Limited | Process for making wines |
| FR2591073B1 (fr) * | 1985-12-10 | 1988-02-19 | Leroux Sarl Chicoree | Boisson a base de chicoree et procede de preparation de ladite boisson |
| JP2003250528A (ja) * | 2002-03-06 | 2003-09-09 | Yakult Honsha Co Ltd | ビフィドバクテリウム属細菌の生残性改善剤、増殖促進剤、又は、同細菌含有醗酵物の製造方法 |
| US20040001898A1 (en) * | 2002-06-26 | 2004-01-01 | Armand Malnoe | Compositions and methods for detoxification and cancer prevention |
| EP1610623B1 (en) * | 2003-03-25 | 2011-11-23 | Aarhus Universitet | Methodologies for improving the quality of meat, health status of animals and impact on environment |
| SE527555C2 (sv) * | 2003-04-04 | 2006-04-11 | Probi Ab | Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar |
| AU2005279724B2 (en) * | 2004-09-01 | 2010-03-25 | Pioneer Hi-Bred International, Inc. | Ferulate esterase producing strains and methods of using same |
| RU2427382C2 (ru) * | 2005-09-28 | 2011-08-27 | Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния | Способ снижения артериального давления у индивидов с состоянием, предшествующим гипертензии, и/или у индивидов с метаболическим синдромом |
| PL1937091T3 (pl) * | 2005-09-28 | 2015-11-30 | Constellation Brands Inc | Ekstrakt z winogron, jego suplement diety i jego przetwarzanie |
| FR2904935A1 (fr) * | 2006-08-18 | 2008-02-22 | Centre Nat Rech Scient | Composition antidiabetique apte a stimuler la secretion d'insuline et destinee au traitement du diabete de type 2 (diabete non insulino-dependant). |
| WO2008028300A1 (en) * | 2006-09-07 | 2008-03-13 | Mcgill University | Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| EP1917960A1 (en) * | 2006-11-06 | 2008-05-07 | Nestec S.A. | Improved biological effects of rosmarinic acid |
| EP1932517A3 (en) * | 2006-12-11 | 2008-07-16 | Universiteit Utrecht Holding B.V. | Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof |
| JP4990297B2 (ja) * | 2007-02-01 | 2012-08-01 | 株式会社Ｔｋバイオ研究所 | ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬 |
| EP1985191A1 (en) * | 2007-04-27 | 2008-10-29 | Universita'degli Studi Di Milano | Preparation of polyfunctional fermented food products |
| MX2010011059A (es) * | 2008-04-30 | 2010-11-12 | Nestec Sa | Composiciones para preparar una bebida de cafe que comprende acido clorogenico hidrolizado. |
| WO2009155689A1 (en) * | 2008-06-24 | 2009-12-30 | Micropharma Limited | Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections |
-
2009
- 2009-01-27 EP EP09151390A patent/EP2210504A1/en not_active Withdrawn
-
2010
- 2010-01-27 WO PCT/EP2010/050914 patent/WO2010086322A1/en active Application Filing
- 2010-01-27 EP EP10702095A patent/EP2391228A1/en not_active Withdrawn
- 2010-01-27 MX MX2011007471A patent/MX2011007471A/es not_active Application Discontinuation
- 2010-01-27 KR KR1020117019447A patent/KR20110119723A/ko not_active Application Discontinuation
- 2010-01-27 AU AU2010209797A patent/AU2010209797A1/en not_active Abandoned
- 2010-01-27 BR BRPI1007194-6A patent/BRPI1007194A2/pt not_active IP Right Cessation
- 2010-01-27 RU RU2011135819/13A patent/RU2011135819A/ru not_active Application Discontinuation
- 2010-01-27 CN CN2010800055521A patent/CN102333455A/zh active Pending
- 2010-01-27 AR ARP100100204A patent/AR075188A1/es not_active Application Discontinuation
- 2010-01-27 US US13/145,656 patent/US20110280848A1/en not_active Abandoned
- 2010-01-27 CA CA2750685A patent/CA2750685A1/en not_active Abandoned
- 2010-01-27 JP JP2011546828A patent/JP2012515541A/ja active Pending
-
2011
- 2011-07-13 CO CO11087834A patent/CO6400174A2/es active IP Right Grant
- 2011-08-26 ZA ZA2011/06300A patent/ZA201106300B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102333455A (zh) | 2012-01-25 |
| BRPI1007194A2 (pt) | 2015-08-25 |
| RU2011135819A (ru) | 2013-03-10 |
| CA2750685A1 (en) | 2010-08-05 |
| US20110280848A1 (en) | 2011-11-17 |
| KR20110119723A (ko) | 2011-11-02 |
| CO6400174A2 (es) | 2012-03-15 |
| WO2010086322A1 (en) | 2010-08-05 |
| AU2010209797A1 (en) | 2011-07-28 |
| EP2210504A1 (en) | 2010-07-28 |
| MX2011007471A (es) | 2011-08-03 |
| EP2391228A1 (en) | 2011-12-07 |
| JP2012515541A (ja) | 2012-07-12 |
| ZA201106300B (en) | 2013-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR075187A1 (es) | Composicon que comprende acido caftarico y/o sus derivados, uso, kit | |
| AR075188A1 (es) | Composicion que comprende acido chicorico y/o sus derivados, uso, kit | |
| MY172363A (en) | Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof | |
| EA201391500A1 (ru) | Синергический противомикробный эффект | |
| CL2011002852A1 (es) | Uso de bacterias del acido lactico probioticas por un tratamiento con calor para la preparacion de composiciones para prevenir o tratar inmunodeficiencias causadas por infecciones bacterianas, virales, fungicas y/o parasitarias. | |
| UA109876C2 (uk) | Композиція, що містить bifidobacterium longum cncm i-2618, для лікування та профілактики імунних розладів | |
| WO2019118984A3 (en) | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome | |
| IN2012DN01638A (es) | ||
| MX347262B (es) | Preparaciones de alimento para mascotas que contienen microorganismos probióticos. | |
| UA109112C2 (uk) | Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями | |
| BR112015024330A2 (pt) | nova bactéria do ácido láctico, medicamento, alimento ou bebida, e ração que contenham a nova bactéria do ácido láctico | |
| MX2013004372A (es) | Productos de confiteria que contienen microorganismos probioticos. | |
| MX354047B (es) | Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. | |
| WO2019004684A3 (ko) | 나노화된 김치 유산균을 함유하는 피부 주름 개선 또는 피부 보습용 화장료 조성물 | |
| MX2011005527A (es) | Uso de la bacteria de acido lactico para tratar o prevenir el eczema. | |
| IN2012DN02283A (es) | ||
| BR112019001984A2 (pt) | bactérias lácticas e a sua utilização para tratamento prevenção, inibição e/ou redução da formação de biofilmes bacterianos | |
| RU2012155852A (ru) | Применение цикориевой кислоты и её производных для регулирования пигментации кожи | |
| MX357554B (es) | Concentrado o extracto de brote de aloe vera que tiene efectos superiores de promoción de célula de la piel, antioxidantes y anti-alergia. | |
| CL2019001194A1 (es) | Extracto de una composición herbal como agente antimicrobiano y/o antibiopelícula. | |
| MX2013003541A (es) | Alimento fermentado y metodo para producir el mismo. | |
| CN105288218A (zh) | 一种益生菌复合物 | |
| RU2012155857A (ru) | Применение цикориевой кислоты и молочнокислых бактерий в биологически активной добавке к пище для регулирования пигментации кожи | |
| RU2013120495A (ru) | Мононенасыщенная жирная кислота для профилактики и/или лечения недостатков цвета и внешнего вида кожи | |
| RU2012155855A (ru) | Применение кафтаровой кислоты и молочнокислых бактерий в биологически активной добавке к пище для регулирования пигментации кожи |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |